Startseite Skin aging by glycation: lessons from the reconstructed skin model
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Skin aging by glycation: lessons from the reconstructed skin model

  • Hervé Pageon EMAIL logo , Hélène Zucchi , Françoise Rousset , Vincent M. Monnier und Daniel Asselineau
Veröffentlicht/Copyright: 15. Juni 2013
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: Aging is the result of several mechanisms which operate simultaneously. Among them, glycation is of particular interest because it is a reaction which affects slowly renewing tissues and macromolecules with elevated half-life, like the dermis, a skin compartment highly affected by aging. Glycation produces crosslinks between macromolecules thereby providing an explanation for the increased age-related stiffness of the skin. Glycation products, also called AGEs (advanced glycation end products), accumulate primarily in extracellular matrix molecules like collagen or elastin.

Methods: In order to reproduce this phenomenon in vitro we have created a model of reconstructed skin modified by glycation of the collagen used to fabricate the dermal compartment.

Results: This system allowed us to uncover biological modifications of dermal markers, and more surprisingly epidermal markers, as well as an increase of metalloproteinases responsible for degradation of the dermal matrix. Consequently, the imbalance between synthesis and degradation that results from glycation, may contribute to skin aging, as shown in this model. Moreover these modifications were shown to be prevented by the addition of aminoguanidine, a well-known inhibitor of glycation.

Conclusions: Using this experimental approach our results taken together stress the importance and possibly central role of glycation in skin aging and the usefulness of the reconstructed skin as a model of physiological aging.


Corresponding author: Hervé Pageon, L’Oréal Research & Innovation, Centre Charles Zviak, 90 rue du Général Roguet, 92583 Clichy Cédex, France, E-mail:

References

1. Zouboulis CC, Makrantonaki E. Clinical aspects and molecular diagnostics of skin aging. Clin Dermatol 2011;29:3–14.10.1016/j.clindermatol.2010.07.001Suche in Google Scholar

2. Verzijl N, DeGroot J, Thorpe SR, Bank RA, Shaw JN, Lyons TJ, et al. Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem 2000;275:39027–31.10.1074/jbc.M006700200Suche in Google Scholar

3. Pageon H. Reaction of glycation and human skin: the effects on the skin and its components, reconstructed skin as a model. Pathol Biol (Paris) 2010;58:226–31.10.1016/j.patbio.2009.09.009Suche in Google Scholar

4. Ravelojaona V, Robert AM, Robert L. Expression of senescence-associated beta-galactosidase (SA-beta-Gal) by human skin fibroblasts, effect of advanced glycation end-products and fucose or rhamnose-rich polysaccharides. Arch Gerontol Geriatr 2009;48:151–4.10.1016/j.archger.2007.12.004Suche in Google Scholar

5. Alikhani M, Alikhani Z, Boyd C, MacLellan CM, Raptis M, Liu R, et al. Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways. Bone 2007;40:345–53.10.1016/j.bone.2006.09.011Suche in Google Scholar

6. Molinari J, Ruszova E, Velebny V, Robert L. Effect of advanced glycation endproducts on gene expression profiles of human dermal fibroblasts. Biogerontology 2008;9:177–82.10.1007/s10522-008-9129-7Suche in Google Scholar

7. Okano Y, Masaki H, Sakurai H. Dysfunction of dermal fibroblasts induced by advanced glycation end-products (AGEs) and the contribution of a nonspecific interaction with cell membrane and AGEs. J Dermatol Sci 2002;29:171–80.10.1016/S0923-1811(02)00021-XSuche in Google Scholar

8. Reihsner R, Melling M, Pfeiler W, Menzel EJ. Alterations of biochemical and two-dimensional biomechanical properties of human skin in diabetes mellitus as compared to effects of in vitro non-enzymatic glycation. Clin Biomech (Bristol, Avon) 2000;15:379–86.10.1016/S0268-0033(99)00085-6Suche in Google Scholar

9. Pageon H, Bakala H, Monnier VM, Asselineau D. Collagen glycation triggers the formation of aged skin in vitro. Eur J Dermatol 2007;17:12–20.Suche in Google Scholar

10. Pageon H, Técher MP, Asselineau D. Reconstructed skin modified by glycation of the dermal equivalent as a model for skin aging and its potential use to evaluate anti-glycation molecules. Exp Gerontol 2008;43:584–8.10.1016/j.exger.2008.04.004Suche in Google Scholar

11. Asselineau D, Bernard B, Bailly C, Darmon M. Epidermal morphogenesis and induction of the 67 kD keratin polypeptide by culture of human keratinocytes at the liquid-air interface. Exp Cell Res 1985;159:536–9.10.1016/S0014-4827(85)80027-6Suche in Google Scholar

12. Nilsson BO. Biological effects of aminoguanidine: an update. Inflamm Res 1999;48:509–15.10.1007/s000110050495Suche in Google Scholar

13. Monnier VM, Mustata GT, Biemel KL, Reihl O, Lederer MO, Zhenyu D, et al. Cross-linking of the extracellular matrix by the Maillard reaction in aging and diabetes: an update on “a puzzle nearing resolution”. Ann N Y Acad Sci 2005;1043: 533–44.10.1196/annals.1333.061Suche in Google Scholar

14. Wu CH, Huang HW, Lin JA, Huang SM, Yen GC. The proglycation effect of caffeic acid leads to the elevation of oxidative stress and inflammation in monocytes, macrophages and vascular endothelial cells. J Nutr Biochem 2011;22:585–94.10.1016/j.jnutbio.2010.05.002Suche in Google Scholar

15. Okano Y, Masaki H, Sakurai H. Pentosidine in advanced glycation end-products (AGEs) during UVA irradiation generates active oxygen species and impairs human dermal fibroblasts. J Dermatol Sci 2001;27(Suppl 1):S11–8.10.1016/S0923-1811(01)00114-1Suche in Google Scholar

16. Jeanmaire C, Danoux L, Pauly G. Glycation during human dermal intrinsic and actinic ageing: an in vivo and in vitro model study. Br J Dermatol 2001;145:10–8.10.1046/j.1365-2133.2001.04275.xSuche in Google Scholar PubMed

Received: 2013-2-4
Accepted: 2013-5-24
Published Online: 2013-06-15
Published in Print: 2014-01-01

©2014 by Walter de Gruyter Berlin Boston

Artikel in diesem Heft

  1. Masthead
  2. Masthead
  3. Editorial
  4. Frontiers in research on the Maillard reaction in aging and chronic disease
  5. Reviews
  6. Role of the Maillard reaction in aging and age-related diseases. Studies at the cellular-molecular level
  7. Advanced glycation end-products and skin autofluorescence in end-stage renal disease: a review
  8. Glucosepane: a poorly understood advanced glycation end product of growing importance for diabetes and its complications
  9. Mini Reviews
  10. Post-translational modification derived products (PTMDPs): toxins in chronic diseases?
  11. Site-specific AGE modifications in the extracellular matrix: a role for glyoxal in protein damage in diabetes
  12. Augmentation of blood lipid glycation and lipid oxidation in diabetic patients
  13. Maillard reaction products: some considerations on their health effects
  14. The Maillard reaction and food allergies: is there a link?
  15. Perspectives
  16. Chelation therapy for the management of diabetic complications: a hypothesis and a proposal for clinical laboratory assessment of metal ion homeostasis in plasma
  17. Genetics and Molecular Diagnostics
  18. Genetic variability in enzymes of metabolic pathways conferring protection against non-enzymatic glycation versus diabetes-related morbidity and mortality
  19. General Clinical Chemistry and Laboratory Medicine
  20. Quantification of glyoxal, methylglyoxal and 3-deoxyglucosone in blood and plasma by ultra performance liquid chromatography tandem mass spectrometry: evaluation of blood specimen
  21. A new HPLC-based assay for the measurement of fructosamine-3-kinase (FN3K) and FN3K-related protein activity in human erythrocytes
  22. Increased circulating advanced glycation endproducts (AGEs) in acute trauma patients
  23. Circulating soluble RAGE increase after a cerebrovascular event
  24. Pentosidine determination in CSF: a potential biomarker of Alzheimer’s disease?
  25. Cardiovascular Diseases
  26. Skin autofluorescence as proxy of tissue AGE accumulation is dissociated from SCORE cardiovascular risk score, and remains so after 3 years
  27. Plasma advanced glycation end products (AGEs) and NF-κB activity are independent determinants of diastolic and pulse pressure
  28. Total plasma Nε-(carboxymethyl)lysine and sRAGE levels are inversely associated with a number of metabolic syndrome risk factors in non-diabetic young-to-middle-aged medication-free subjects
  29. Translational Research Papers
  30. Advanced glycation end-products induce endoplasmic reticulum stress in human aortic endothelial cells
  31. Formation of nitri- and nitrosylhemoglobin in systems modeling the Maillard reaction
  32. Skin aging by glycation: lessons from the reconstructed skin model
  33. How to help the skin cope with glycoxidation
Heruntergeladen am 16.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2013-0091/html
Button zum nach oben scrollen